Prelude Therapeutics CEO Krishna Vaddi's 2023 pay slips 20% to $2.6M
Prelude Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 26, 2024
Prelude Therapeutics reported fiscal year 2023 executive compensation information on April 26, 2024.
In 2023, three executives at Prelude Therapeutics received on average a compensation package of $2M, a 25% decrease compared to previous year.
Average pay of disclosed executives at Prelude Therapeutics
Krishna Vaddi, Chief Executive Officer, received $2.6M in total, which decreased by 20% compared to 2022. 66% of Vaddi's compensation, or $1.7M, was in option awards. Vaddi also received $331K in non-equity incentive plan, $573K in salary, as well as $2.6K in other compensation.
Jane Huang, Chief Medical Officer, received a compensation package of $1.7M, which decreased by 43% compared to previous year. 48% of the compensation package, or $789K, was in option awards.
Bryant D. Lim, Chief Financial Officer, earned $1.6M in 2023.
Related executives
You may also like
Source: SEC filing on April 26, 2024.